Zobrazeno 1 - 10
of 11
pro vyhledávání: '"M Rodríguez Goicoechea"'
Autor:
M Rodríguez Goicoechea, MA Calleja Hernández, L Gutiérrez Zúñiga, Caparrós Romero, M Ferrit Martin
Publikováno v:
European Journal of Hospital Pharmacy. 23:A78.3-A79
Background The safety of biologic agents for the treatment of psoriasis has been studied in long term clinical trials with up to 5 years of follow-up. However, observational studies provide the potential to identify safety signals in a real world set
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2d67d20586053a1ed0cfc5ff7e84661
https://doi.org/10.1136/ejhpharm-2016-000875.178
https://doi.org/10.1136/ejhpharm-2016-000875.178
Autor:
FI Sánchez Osorio, PM Rodríguez Gómez, M Rodríguez Goicoechea, L Gutiérrez Zúñiga, Caparrós Romero
Publikováno v:
European Journal of Hospital Pharmacy. 23:A78.1-A78
Background At least 50% of patients admitted to hospital for surgery take medicines to treat chronic diseases. Some medicines may interact with drugs used during surgery, but there are few situations that contraindicate this use. Most drugs must be m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85c88612f7acab46f135b2c5c9bed596
https://doi.org/10.1136/ejhpharm-2016-000875.176
https://doi.org/10.1136/ejhpharm-2016-000875.176
Autor:
MA Calleja Hernández, L Gutiérrez Zúñiga, Caparrós Romero, M Rodríguez Goicoechea, M Ferrit Martin
Publikováno v:
European Journal of Hospital Pharmacy. 23:A76.1-A76
Background Administration of cytokines, such as interleukin 2 and interferon α, has been clinically proven since the 1980s, but today their use in clinical practice has decreased considerably due to the effectiveness of new target treatments, such a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3c939fc5b2eac6fe00d88dc5cb0981b
https://doi.org/10.1136/ejhpharm-2016-000875.172
https://doi.org/10.1136/ejhpharm-2016-000875.172
Autor:
M Rodríguez Goicoechea, FJ Nieto Cobo, FI Sánchez Osorio, PM Rodríguez Gómez, Caparrós Romero
Publikováno v:
European Journal of Hospital Pharmacy. 23:A244.2-A245
Background Reconciliation errors (RE) represent a security problem and have been identified by organisations such as the Institute for Healthcare Improvement (IHI) and the Joint Commission on Accreditation of Healthcare Organisations (JCAHO) as a pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c075d91062da68802c4dd132a0a45b71
https://doi.org/10.1136/ejhpharm-2016-000875.554
https://doi.org/10.1136/ejhpharm-2016-000875.554
Autor:
M Rodríguez Goicoechea, L Rodriguez Cardenas, B Cancela Díez, M Garzón Muñoz, AI Fernández Cardenas, ML García Mellado
Publikováno v:
European Journal of Hospital Pharmacy. 23:A57.1-A57
Background Trastuzumab is the main treatment of HER-2 positive breast cancer. Its administration intravenously has shown an extension of survival not only in early stage but also in advance stage tumours. With the inclusion of subcutaneous formulatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71a822e40184b4e68117702d7169b870
https://doi.org/10.1136/ejhpharm-2016-000875.130
https://doi.org/10.1136/ejhpharm-2016-000875.130
Autor:
Rocío López-Sepúlveda, M Rodríguez Goicoechea, ME Espínola García, S Anaya Ordóñez, F Artime Rodríguez, M Carrasco Gomariz, Martín Sances, J Cabeza Barrera, MA García Lirola
Publikováno v:
European Journal of Hospital Pharmacy. 23:A4.2-A4
Background In some regions, the pharmaceutical services at nursing homes are held by pharmacists from hospitals in the public network. Purpose To determine the impact of medicines reconciliation on the prevalence of potentially inappropriate medicine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4232deebc45044ad9a4dfe3fd4465aaf
https://doi.org/10.1136/ejhpharm-2016-000875.9
https://doi.org/10.1136/ejhpharm-2016-000875.9
Autor:
M Carrasco Gomariz, Rocío López-Sepúlveda, N Martinez Casanova, M Rodríguez Goicoechea, F Artime Rodríguez, I. Vallejo Rodríguez, J Cabeza Barrera, MA Calleja Hernández
Publikováno v:
European Journal of Hospital Pharmacy. 23:A3.2-A4
Background The switch from the intravenous (IV) formulation to the subcutaneous (SC) formulation of abatacept (ABA) had been analysed in clinical trials but there are few data regarding the effectiveness and safety of the SC formulation in clinical p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c199236cf00e40e8bb8884b9cb110ee
https://doi.org/10.1136/ejhpharm-2016-000875.7
https://doi.org/10.1136/ejhpharm-2016-000875.7
Publikováno v:
European Journal of Hospital Pharmacy. 23:A103.1-A103
Background Regorafenib is an oral multi-kinase approved by the European Medicines Agency (EMA) for the treatment of metastatic colorectal cancer (mCRC) in patients who have failed treatment with fluoropyrimidine, oxaliplatin and irinotecan based chem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50f656af8217f43f09cf80af8204746a
https://doi.org/10.1136/ejhpharm-2016-000875.233
https://doi.org/10.1136/ejhpharm-2016-000875.233
Autor:
T Simon Sanchez, MA Calleja Hernández, JE Micó González, M Ferrit Martin, A Jiménez Morales, SE De Jesús, M Rodríguez Goicoechea
Publikováno v:
European Journal of Hospital Pharmacy. 23:A165.2-A165
Background Medical gases (MG) have traditionally been managed by maintenance units. With the new legislation, this management has been taken over by the pharmacy departments. Purpose To measure the economic impact and describe the efficiency measures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c7790a65f7cee9f6ca5106f722333da
https://doi.org/10.1136/ejhpharm-2016-000875.372
https://doi.org/10.1136/ejhpharm-2016-000875.372
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.